Gain Therapeutics, Inc.
Public company- Headquarters
- BETHESDA, Maryland
- Ticker
- GANX
- CIK
- 0001819411
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Vice President, FinanceJeanette Weidner | Oct 28, 2026 | Appointed |
| CFOGianluca Fuggetta | Sep 28, 2026 | Departed |
| CFOGene Mack | Sep 28, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- MACROGENICS INC
Class II Director appointed: Michael Vasconcelles
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- Executive appointment
Vice President, Finance appointed: Jeanette Weidner
Jeanette Weidner was named Vice President, Finance of Gain Therapeutics, Inc., effective October 28, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 28, 2026Role: Vice President, Finance
- Executive departure
CFO departs: Gianluca Fuggetta
Gianluca Fuggetta, Senior Vice President of Finance, principal financial officer, and principal accounting officer of Gain Therapeutics, Inc., resigns the role, effective September 30, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 28, 2026Role: Senior Vice President of Finance, principal financial officer, and principal accounting officer
- Executive appointment
CFO appointed: Gene Mack
Gene Mack was named interim Chief Financial Officer of Gain Therapeutics, Inc., effective October 1, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 28, 2026Role: interim Chief Financial Officer
Last verified Nov 8, 2026